Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis (Q33633882)

28 July 2017

title

Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis (English)

1 reference

28 July 2017

1 reference

6

Stefanie Dimmeler

0 references

Gian Paolo Fadini

Gian Paolo Fadini

1

0 references

Andreas Zeiher

7

Andreas M Zeiher

1 reference

28 July 2017

12

Nikos Werner

1 reference

28 July 2017

10

Georg Nickenig

1 reference

Saula Vigili de Kreutzenberg

28 July 2017

8

Saula de Kreutzenberg

1 reference

28 July 2017

Caroline Schmidt-Lucke

11

Caroline Schmidt-Lucke

1 reference

28 July 2017

9

Angelo Avogaro

1 reference

28 July 2017

Shoichi Maruyama

2

1 reference

28 July 2017

Takenori Ozaki

3

1 reference

28 July 2017

Akihiko Taguchi

4

1 reference

28 July 2017

James Meigs

5

1 reference

28 July 2017

language of work or name

English

0 references

publication date

9 July 2010

1 reference

full work available at URL

28 July 2017

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901328

0 references

published in

PLOS One

1 reference

28 July 2017

volume

5

1 reference

28 July 2017

issue

7

1 reference

28 July 2017

page(s)

e11488

1 reference

Creative Commons Attribution 4.0 International

28 July 2017

copyright license

start time

9 July 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Endothelial progenitor cells in the natural history of atherosclerosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Use and misuse of the receiver operating characteristic curve in risk prediction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Multiple biomarkers for the prediction of first major cardiovascular events and death

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Anti-bovine CD34 monoclonal antibody reveals polymorphisms within coding region of the CD34 gene

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Estimation of time-dependent area under the ROC curve for long-term risk prediction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Circulating endothelial progenitor cells and cardiovascular outcomes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Mendelian randomization: prospects, potentials, and limitations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Inflammation in atherosclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Isolation of putative progenitor endothelial cells for angiogenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

The Natural History of Congestive Heart Failure: The Framingham Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

The estimation of synergy or antagonism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901328

Prevalence of conventional risk factors in patients with coronary heart disease

21 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011488

Circulating CD34-positive cells provide an index of cerebrovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011488

Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011488

Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011488

On the estimation of additive interaction by use of the four-by-two table and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011488

The CXCL12-3'A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011488

Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011488

Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011488

Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011488

Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011488

Circulating endothelial progenitors--cells as biomarkers

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/20634884

12 December 2020

Nonpharmacological treatment of hypercholesterolemia increases circulating endothelial progenitor cell population in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/20634884

12 December 2020

Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/20634884

12 December 2020

Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20634884

12 December 2020

10.1371/JOURNAL.PONE.0011488

Identifiers

DOI

1 reference

28 July 2017

0 references

1 reference

28 July 2017

1 reference